Top compounds associated with response to KIAA1161


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA alvocidib CTRPv2 pan-cancer AAC -0.027 0.6
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA Erlotinib UHNBreast pan-cancer AAC 0.15 0.6
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.018 0.6
mRNA Cisplatin GDSC1000 pan-cancer AAC -0.018 0.6
mRNA barasertib CTRPv2 pan-cancer AAC -0.017 0.6
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.015 0.6
Download CSV